Title: VACCELERATE - The New European Vaccine Research Network
Design: Phase 2 & 3 COVID-19 vaccine clinical trials
Registration Number: n.a.
Primary Objective: VACCELERATE will be established as the network for pandemic preparedness in Europe. The goal is to plan and coordinate phase 2 & 3 vaccine trials in all EU-member states and EU-associated countries under one strategic-scientific umbrella. It will serve as single-entry point for all stakeholders involved in COVID-19 vaccine development (pharma, academia, European Commission, EMA, ECDC, national health authorities and others).
To address any research question outside the big registration trials, such as vaccine efficacy in case of virus variants, trials in children, pregnant women and immuno- compromised patients, trials on combination of different vaccines etc.
Creation of a Stakeholder Working Group (SWG) to facilitate strategic discussions and to identify unanswered public health needs.
Promotion of a harmonised acquisition, open exchange and consolidation of data for enhanced data analysis across trial through the setting up of volunteer registries.
Additionally, VACCELERATE will address vaccine hesitancy through systematic reviews of available information and through specific information material to dispel myths about vaccines and clinical trials.
Interested in a collaboration? Contact: Anna Maria Azzini firstname.lastname@example.org
Klinikum Der Universitaet Zu Koeln (UHC),
Biomedicinske Centrum Slovenskej Akademie Vied,
Centro Hospitalar Universitario Do Porto Epe,
Kentro Klinikis Epidimiologias Kai Ekvasis Nosimaton,
Ecrin European Clinical Research Infrastructure Network,
European University Cyprus,
European Vaccine Initiative Ewiv,
Institut National De La Sante Et De La Recherche Medicale (INSERM),
Instituto De Salud Carlos III,
University of Belgrade,
Ministry of Health Israel,
Uniwersytet Medyczny W Bialymstoku,
Medizinische Universitaet Wien,
University College Dublin,
Region Hovedstaden (Regionh),
University of Antwerp,
University of Bern,
University of Bergen,
University of Utrecht,
University of Paris,
Viesoji Istaiga Vilniaus Universiteto Ligonine Santaros Klinikos,
Anna Maria Azzini
Ruth Joanna Davis